Bioceres Crop Solutions (NASDAQ:BIOX) Given New $13.00 Price Target at Lake Street Capital

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price decreased by Lake Street Capital from $25.00 to $13.00 in a report released on Wednesday morning, Benzinga reports. Lake Street Capital currently has a buy rating on the stock.

A number of other research firms have also issued reports on BIOX. Roth Mkm started coverage on Bioceres Crop Solutions in a report on Tuesday, July 2nd. They issued a buy rating and a $15.00 target price for the company. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a strong-buy rating in a research note on Friday, July 19th. Roth Capital raised Bioceres Crop Solutions to a strong-buy rating in a research report on Tuesday, July 2nd. Finally, Canaccord Genuity Group restated a buy rating and set a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Bioceres Crop Solutions has an average rating of Buy and a consensus target price of $13.63.

Bioceres Crop Solutions Stock Performance

Shares of BIOX stock opened at $8.56 on Wednesday. The business’s fifty day simple moving average is $10.43 and its 200-day simple moving average is $11.41. Bioceres Crop Solutions has a 12-month low of $8.16 and a 12-month high of $14.05. The company has a market cap of $537.57 million, a PE ratio of 856.00 and a beta of 0.49. The company has a current ratio of 1.28, a quick ratio of 0.83 and a debt-to-equity ratio of 0.35.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). The firm had revenue of $124.30 million for the quarter, compared to analysts’ expectations of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. During the same period last year, the firm posted ($0.06) earnings per share. Analysts expect that Bioceres Crop Solutions will post 0.81 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Institutional investors and hedge funds have recently modified their holdings of the company. Fourth Sail Capital LP increased its holdings in shares of Bioceres Crop Solutions by 20.5% in the 2nd quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after acquiring an additional 334,195 shares during the period. Long Focus Capital Management LLC grew its holdings in Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after buying an additional 46,647 shares during the period. Wellington Management Group LLP lifted its position in Bioceres Crop Solutions by 3.1% during the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after buying an additional 7,096 shares in the last quarter. Oak Family Advisors LLC increased its holdings in Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after buying an additional 1,208 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after acquiring an additional 5,341 shares during the period. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.